The provided text discusses the financial statements, comprehensive income, balance sheets, shareholders' equity, earnings per share, share-based compensation, retirement benefits, risk management activities, fair value measurements, restructuring programs, commitments, and contingencies of The Procter & Gamble Company. It covers various aspects such as the Company's net earnings, comprehensive income, shareholders' equity, assets, liabilities, restructuring costs, earnings per share calculation, share-based compensation expenses, post-retirement benefits, risk management activities, fair value measurements, commitment to restructuring programs, and legal contingencies. It also touches on brand goodwill, intangible assets, and income tax uncertainties. The information is detailed and provides a comprehensive insight into the financial aspects and operations of the company.
The text discusses forward-looking statements included in a financial report, emphasizing the risks and uncertainties associated with various factors that may impact the company's financial condition and results. These factors include managing global financial risks, economic volatility, disruptions in credit markets, supply chain disruptions, cost fluctuations, responding to competitors, regulatory requirements, and changes in tax laws. The Management's Discussion and Analysis (MD&A) provides an overview of the company's financial condition, operational results, and cash flows, organized into sections like "Summary of Results" and "Economic Conditions and Uncertainties." It highlights the company's business segments, product categories, and major brands. Additionally, it presents key financial data, such as net sales and earnings for different segments, and provides a summary of the company's performance for the nine months ended March 31, 2021. Factors such as managing global financial risks, cost fluctuations, tax laws, and challenges related to the COVID-19 pandemic are discussed in detail. Furthermore, the text discusses an increase in operating income and net earnings for the company, driven by factors such as a gain on equity investments, improvements in defined benefit retirement plans, and sales growth across various business segments like Beauty, Grooming, and Health Care. Specific sales and earnings data for different business segments over three- and nine-month periods are provided, detailing the influencing factors on net sales, earnings before income taxes, and net earnings for each segment. The text also compares performance between current and prior year periods for each business segment, highlighting the impact of income taxes on the company's financials, particularly regarding the effective tax rate and various contributing factors.
There have been no significant changes in the company's market risk exposure since June 30, 2020, and more details can be found in Note 7 of the Consolidated Financial Statements regarding risk management activities and fair value measurements.
The text discusses the evaluation of disclosure controls and procedures by the Company's Chairman of the Board, President, and CEO, David S. Taylor, and the Chief Financial Officer, Andre Schulten. They concluded that the disclosure controls and procedures were effective to ensure timely and accurate reporting of information required by the Securities Exchange Act. There were no changes in internal control over financial reporting during the fiscal quarter that materially affected the company's internal control.
The text explains that the company is involved in various legal proceedings and claims related to different aspects of its business. However, for the current period, there are no significant legal matters that need to be disclosed under this item.
The text provides a reference to "Risk Factors" in Part I, Item 1A of a company's Form 10-K/A for the year ended June 30, 2020, for information on risk factors.
The text provides information on the issuer's unregistered sales of equity securities, specifically detailing the total number of shares purchased, average price paid per share, and the total number of shares purchased as part of publicly announced plans or programs for the periods from January 1, 2021, to March 31, 2021. It also mentions that the company plans to reduce outstanding shares through direct share repurchases at a value of approximately $11 billion in fiscal year 2021, with purchases authorized by the company's Board of Directors and expected to be financed by a combination of operating cash flows and debt issuance.
I'm ready to assist whenever you're ready!
Please provide me with the text that you would like me to summarize.
I am ready to summarize the text whenever you are ready to provide it.
The text provided includes various exhibits related to a company's articles of incorporation, regulations, separation agreements, certifications, and XBRL documents. It mentions filings with the Securities and Exchange Commission, as well as the signing of reports by the company's designated officer. These exhibits are part of a regulatory filing by The Procter & Gamble Company as of April 20, 2021.
